Clinical Trials Directory

Trials / Completed

CompletedNCT04449796

Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients

Status
Completed
Phase
Study type
Observational
Enrollment
1,025 (actual)
Sponsor
Frisius Medisch Centrum · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of body composition, changes with the physical condition of patients and is associated with survival in several disease states and during ICU admission. Aim of the study is to explore the predictive value of the phase angle for long term ICU outcome.

Detailed description

Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of body composition, changes with the physical condition of patients and is associated with survival in several disease states and during ICU admission. Aim of the study is to explore the predictive value of the phase angle for long term ICU survival. A single-centre prospective observational cohort will be performed with consecutive patients, elective and non elective, admitted to the ICU between 1st June 2018 and 1st June 2019. Demographic data, APACHE III, comorbidity and phase angle are collected and the ICU- , hospital- and 6 months survival will be registered.

Conditions

Timeline

Start date
2018-06-01
Primary completion
2019-06-01
Completion
2020-06-01
First posted
2020-06-29
Last updated
2020-07-09

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04449796. Inclusion in this directory is not an endorsement.

Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients (NCT04449796) · Clinical Trials Directory